Insider Trading News

Three insiders buy Bambusa Therapeutics, Inc. shares, $58.6M in total

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Three insiders buy Bambusa Therapeutics, Inc. shares, $58.6M in totalThree insiders buy Bambusa Therapeutics, Inc. shares, $58.6M in total

Open-market purchases on Nov 2, led by RA Capital Management, L.P. (director). Information only, not investment advice.

Three insiders at Bambusa Therapeutics, Inc. (BBTX) bought shares on the open market on Nov 2, a combined $58.6 million, according to Form 4 filings with the SEC.

By size, RA Capital Management, L.P., a director, leads with $46.6 million. Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy.

Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan. The table below lists who bought, when, and at what price.

Details from the SEC filing:

Who bought when
InsiderRoleTrade dateSharesAvg. priceValueFiling
Helmut Wolfgang JeggleDirectorNov 2375,000$16.00$6,000,000App · SEC
Salvia Investment GmbH10% ownerNov 2375,000$16.00$6,000,000App · SEC
RA Capital Management, L.P.DirectorNov 22,953,820$15.79$46,639,958App · SEC
Total$58,639,958

See more details on these BBTX insider trades

Each row of the table links to its Form 4 on SEC.gov.

Browse the latest insider buying · Read more BBTX insider trading news

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.